AlpVHHs

AlpVHHs provides custom antibody services focused on VHHs, also known as nanobodies. Its work covers custom immunization programs, VHH library construction, lead-candidate screening, and long-term co-development arrangements. The company supplies recombinant secondary antibodies, recombinant antibodies, large VHH libraries, test kits, antibody internalization solutions, adjuvants, and IP and co-IP kits. These offerings support antibody discovery, experimental research, and therapeutic and diagnostic development projects. Collaboration formats are structured around individual project requirements, from early discovery activities through candidate evaluation and joint development.

Operations combine an alpaca breeding base with immunization workflows and high-throughput screening platforms for species-specific VHH discovery. This model supports the generation and screening of VHH candidates from alpaca immunization programs. The company works with biotechnology businesses, pharmaceutical companies, and contract research organizations involved in therapeutic and diagnostic development. Its collaboration practices include transparent communication and intellectual-property-friendly terms, including IP and co-IP arrangements. The available antibody, library, screening, internalization, and testing resources can be applied by research organizations seeking VHH-based candidates and related reagents for development programs.